BackiRhythm Technologies Overview
iRhythm Technologies Inc

iRhythm Technologies Target Price

Where could IRTC trade next? Consensus target price: $170.

Get informed when a big investor buys or sells

+ Follow

Share Price

$111.43

Average Target Price

$167.6050.4% upside

10 analysts in the last 4 months

High: $196 | Low: $150

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-18Wells Fargo$16850.8% upsideOpen
2026-08-10Truist Financial$16850.8% upsideOpen
2026-08-07Evercore ISIVijay Kumar$16548.1% upsideOpen
2026-08-07Robert W. Baird$16548.1% upsideOpen
2026-08-07Canaccord Genuity$19675.9% upsideOpen
2026-08-07NeedhamDavid Saxon$19272.3% upsideOpen
2026-07-22Stephens$16043.6% upsideOpen
2026-07-16Truist FinancialRichard Newitter$16043.6% upsideOpen
2026-07-06Evercore ISIVijay Kumar$15034.6% upsideOpen
2026-06-01Canaccord GenuityWilliam Plovanic$15236.4% upsideOpen
2026-05-01Truist Financial$17456.2% upsideOpen
2026-05-01Robert W. Baird$17557% upsideOpen
2026-05-01Evercore ISI$16043.6% upsideOpen
2026-05-01Oppenheimer$18566% upsideOpen
2026-05-01Needham$255128.8% upsideOpen
2026-05-01Canaccord Genuity$18061.5% upsideOpen
2026-04-15Truist FinancialRichard Newitter$17052.6% upsideOpen
2026-02-23Goldman Sachs$18465.1% upsideOpen
2026-02-20Truist FinancialRichard Newitter$20079.5% upsideOpen
2026-02-20Robert W. Baird$20079.5% upsideOpen
2026-01-13Wells Fargo$225101.9% upsideOpen
2026-01-09Goldman Sachs$21189.4% upsideOpen
2026-01-05Evercore ISIVijay Kumar$21088.5% upsideOpen
2025-12-18Truist Financial$21592.9% upsideOpen
2025-12-02Morgan Stanley$20584% upsideOpen
2025-10-31Goldman SachsDavid Roman$20281.3% upsideOpen
2025-10-31Oppenheimer$225101.9% upsideOpen
2025-10-31Robert W. BairdDavid Rescott$235110.9% upsideOpen
2025-10-31Loop Capital MarketsGene Mannheimer$22097.4% upsideOpen
2025-10-31Canaccord Genuity$21290.3% upsideOpen
2025-10-31NeedhamDavid Saxon$244119% upsideOpen
2025-10-15Truist FinancialRichard Newitter$20584% upsideOpen
2025-10-13UBS$19575% upsideOpen
2025-10-10Robert W. BairdDavid Rescott$22097.4% upsideOpen
2025-09-29Canaccord Genuity$19373.2% upsideOpen
2025-08-28NeedhamDavid Saxon$19373.2% upsideOpen
2025-07-14BTIGMarie Thibault$16548.1% upsideOpen
2025-05-05Truist FinancialRichard Newitter$14631% upsideOpen
2025-01-08OppenheimerSuraj Kalia$1207.7% upsideOpen
2024-10-31NeedhamMichael Matson$9613.8% downsideOpen
2024-10-22Truist FinancialDavid Rescott$9514.7% downsideOpen
2024-10-15Robert W. BairdDavid Rescott$10010.3% downsideOpen
2024-10-14Truist FinancialRichard Newitter$8028.2% downsideOpen
2024-10-04Goldman SachsDavid Roman$7830% downsideOpen
2024-09-25Canaccord GenuityWilliam Plovanic$13722.9% upsideOpen
2024-08-02Truist FinancialRichard Newitter$1175% upsideOpen
2024-08-02OppenheimerSuraj Kalia$14530.1% upsideOpen
2024-08-02BTIGMarie Thibault$12512.2% upsideOpen
2024-07-16Truist FinancialRichard Newitter$13420.3% upsideOpen
2024-06-20Wolfe ResearchMike Polark$1153.2% upsideOpen

iRhythm Technologies (IRTC) FAQ

The latest target price for IRTC is $170. Investors often review this figure alongside iRhythm Technologies's historical trend and sector peers before judging valuation or financial health.

iRhythm Technologies trades near $111.43 while the consensus target sits at $170 (50.4% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting IRTC's target price ($170), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack iRhythm Technologies's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.